Nuwellis (NASDAQ:NUWE) Announces Quarterly Earnings Results

Nuwellis (NASDAQ:NUWE) announced its earnings results on Tuesday. The company reported ($0.65) earnings per share for the quarter, missing the consensus estimate of ($0.43) by ($0.22), Zacks reports. Nuwellis had a negative net margin of 169.54% and a negative return on equity of 28,159.25%.

Nuwellis Stock Down 5.2 %

Nuwellis stock traded down $0.07 during midday trading on Tuesday, reaching $1.20. The stock had a trading volume of 89,423 shares, compared to its average volume of 994,423. Nuwellis has a 52-week low of $0.92 and a 52-week high of $17.85. The company has a fifty day moving average of $1.21 and a 200 day moving average of $1.34. The firm has a market cap of $5.23 million, a price-to-earnings ratio of -0.01 and a beta of 0.36.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.